Lower Th-1/Th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C

Digestive Diseases and Sciences

Volumn 47, Issue 10, 2002, Pages 2163-2169

  Masaki, Naohiko ^a   Fukushima, Sugano ^a   Hayashi, Shigeki ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Helper T cell subpopulations; Hepatitis C virus; Interferon; Th 1 Th 2 imbalance

Indexed keywords

CYTOKINE; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENOTYPE; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL; TH1 CELLS; TH2 CELLS; TREATMENT OUTCOME;

EID: 0036796927     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020114722763     Document Type: Article

References (25)

1. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou JP, Erlinger S: Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050-1056, 1995
2. Martinot-Peignoux M, Boyer N, Pouteau M, Castelnau C, Giuily N, Duchatelle V, Auperin A, Degott C, Benhamou JP, Erlinger S, Marcellin P: Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. J Hepatol 29:214-223, 1998
3. Knolle PA, Kremp S, Hohler T, Krummenauer F, Schirmacher P, Gerken G: Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up. J Viral Hepatitis 5:399-406, 1998
4. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C: Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96:224-230, 1995
5. Enomoto N, Sakuma J, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C: Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334:77-81, 1996
6. Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K, Kumada H: Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 25:745-749, 1997
7. Vandelli C, Renzo F, Braun HB, Tisminetzky S, Albrecht M, De Palma M, Ranzi A, Di Marco G, Stroffolini T, Baralle F, Ventura E, Michel G: Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C. J Med Virol 58:26-34, 1999
8. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Kumada H: Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 19:1088-1094, 1994
9. Yosḣioka K, Higashi Y, Yamada M, Aiyama T, Takayanagi M, Tanaka K, Okumura A, Iwata K, Kakumu S: Predictive factors in the response to interferon therapy in chronic hepatitis C. Liver 15:57-62, 1995
10. Shindo M, Arai K, Okuno T. The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C. J Hepatol 26:492-497, 1997
11. Kim SR, Hayashi Y, Yoon S, Taniguchi M, Yang MK, Kim KI, Kim MM, Saeki K, Nukata I, Imoto S: Prediction of efficacy of interferon treatment of chronic hepatitis C by multivariate analysis and a new classification. Pathol International 48:215-220, 1998
12. + subset regulation in viral infection: preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol 148:182-188, 1992
13. + Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest 95:2979-2985, 1995
14. Peng SL, Moslehi J, Craft J: Roles of interferon-γ and interleukin-4 in murine lupus. J Clin Invest 99:1936-1946, 1997
15. Segal R, Bermas BL, Dayan M, Kalush F, Shearer GM, Mozes E: Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease. J Immunol 158:3009-3016, 1997
16. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW: Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24:759-765, 1996
17. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM: Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology 24:6-9, 1996
18. Tsai S-L, Liaw Y-F, Chen M-H, Huang C-Y, Kuo GC: Detection of type2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25:449-458, 1997
19. + T cells in chronic hepatitis C virus infection. Am J Gastroenterol 95:227-232, 2000
20. Reiser M, Marousis CG, Nelson DR, Lauer G, Gonzalez-Peralta RP, Davis GL, Lau JYN: Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol 26:471-478, 1997
21. Eckels DD, Tabatabail N, Bian T-H, Wang H, Muheisen SS, Rice CM, Yoshizawa K, Gill J: In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation. Hum Immunol 60:187-199, 1999
22. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 383:787-793, 1996
23. Rehermann B, Chisari FV: Cell mediated immune response to the hepatitis C virus. Curr Topics Microbiol Immunol 242:299-325, 2000
24. Saito H, Ebinuma H, Satoh I, Miyaguchi S, Tada S, Iwabuchi N, Kumagai N, Tsuchimoto K, Morizane T, Ishii H: Immunological and virological predictors of outcome during interferon-α therapy of chronic hepatitis C. J Viral Hepatitis 7:64-74, 2000
25. Yee LJ, Tang J, Gibson AW, Kimberly R, van Leeuwen DJ, Kaslow RA: Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 33:708-712, 2001